5248042026-10-025248042026-10-022026-10-025248042026-10-02in-capmkt:FinancialYear1Member5248042026-10-02in-capmkt:FinancialYear2Member5248042026-10-02in-capmkt:FinancialYear3Member5248042026-10-022026-10-02in-capmkt:FinancialYear1Member5248042026-10-022026-10-02in-capmkt:FinancialYear2Member5248042026-10-022026-10-02in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure524804AUROBINDO PHARMA LIMITEDAUROPHARMANOTLISTEDINE406A01037NewAcquisition (including agreement to acquire)false2026-10-0203:30:002026-10-02A1 Biochem USA IncStep Down SubsidiaryA1 Biochem Labs LLC533100000176600000493600000true2026-07-23falsefalsetruePharmaceuticals industryThe transaction aligns with the Company’s strategic objective of expanding its presence in the life cycle of Active Pharmaceutical Ingredients (API) business. Apitoria and A1 Labs India are currently engaged in large-scale, regulatory-compliant API manufacturing. Through this acquisition of front-end research and development capability, the Company will be able to create a dedicated Contract Research, Development and Manufacturing (CRDMO) platform. It will expand the portfolio of the Company facilitating full service, longer life cycle engagement with the customers. This transaction is complementary to the current API manufacturing business of Apitoria and A1 Labs India.NofalseThe acquisition has been completed on 2nd October 2026 subject to customary conditions prescribed under the Definitive Agreements.Cash1462000000Cash consideration of USD 15.247 Mn. A1 Labs LLC does not have share capital represented by shares. A1 USA Inc has acquired 100% membership interest in A1 Labs LLC for the aforementioned consideration.146200000001A1 Labs LLC is engaged in providing contract research and chemistry services to pharmaceutical companies, biotechnology companies, including custom synthesis and medicinal chemistry. A1 Labs LLC operates through a leased scientific laboratory located in Wilmington, North Carolina. A1 Labs LLC was incorporated in September 2015 with the registered office in Wilmington, North Carolina, USA. A1 Labs LLC’s turnover during the last three calendar years is as follows: 31st December 2023: USD 6.35 Million 31st December 2024: USD 9.23 Million 31st December 2025: USD 5.92 Million2025-20255331000002024-20248311000002023-2023571600000United States of America